Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

PCAC Votes this Morning to Add 4 Additional Drugs to "Do Not Compound" List

Wednesday, June 17, 2015   (0 Comments)
Posted by: Dagmar Anderson
Share |
IACP representatives David Miller, CEO/EVP and Cynthia Blankenship, VP Government Affairs, are reporting direct from the FDA's Pharmacy Compounding Advisory Committee meeting in White Oak, Maryland...

The PCAC voted this morning to add four additional drugs to the "do not compound" list that have been withdrawn or removed from the market for safety concerns or lack of efficacy.  They are:

Acetaminophen: all drug products containing more than 325mg of acetainophen per dosage unit
Aprotinin:  all drug products containing aprotinin Ondansetron HCl: all IV drug products containing greater than a 16mg, single dose of odansetron Bromocriptine Mesylate: all drug products containing bromocriptine mesylate for prevention of physiological lactation

These four will be in addition to the 26 medications voted on by the PCAC at their first meeting in February 2015. Although the Committee has voted to add these medications to the existing list, that will not become formal until accepted by the Secretary of Health and Human Services and published in the Federal Register. IACP will alert its members when the updated list goes into effect.

Association Management Software Powered by YourMembership  ::  Legal